Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Positive on Workdays Outlook with Upgraded Ratings and Price Targets

Elaine Mendonca by Elaine Mendonca
February 13, 2024
in Breaking News
0
Biotechnology Stock Exchange
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

As of February 13, 2024, the recent assessments of Workday (NASDAQ: WDAY) by analysts have presented a diverse range of viewpoints, but overall, there seems to be a consensus leaning towards a positive outlook. In the past three months, a total of 21 analysts have provided their ratings, with the majority expressing a positive sentiment.

The breakdown of the ratings is as follows:
– Bullish: 4 analysts
– Somewhat Bullish: 14 analysts
– Indifferent: 3 analysts
– Somewhat Bearish: 0 analysts
– Bearish: 0 analysts

However, in the last 30 days, there has been a slight shift in sentiment, with only one analyst providing a somewhat bullish rating and no other changes reported.

When considering the 12-month price targets for Workday, the average stands at $289.14, with a high estimate of $338.00 and a low estimate of $245.00. This indicates an 11.81% increase compared to the previous average price target of $258.61.

Notably, several analysts have recently adjusted their ratings and price targets for Workday:

– Daniel Jester from BMO Capital has upgraded his rating to Outperform, setting a price target of $338.00, which is an increase from the previous target of $290.00.

– Patrick Walravens from JMP Securities has also raised his price target to $315.00 from $270.00 while maintaining a Market Outperform rating.

– Brent Bracelin from Piper Sandler has maintained an Overweight rating and increased his target from $300.00 to $330.00.

– Siti Panigrahi from Mizuho has raised the target to $290.00 from $260.00 and given a Buy rating.

– Brad Reback from Stifel has raised his Hold rating target to $250.00 from $230.00.

– Keith Weiss from Morgan Stanley has raised his Overweight rating target to $295.00 from $245.00.

– David Hynes from Canaccord Genuity has raised his Buy rating target to $290.00 from $260.00.

Overall, the consensus rating for Workday is a Strong Buy, based on 24 buy ratings and 8 hold ratings, with no sell ratings reported. The average price target is $288.27, which represents a slight decrease from the current price of $294.4.

Workday Inc. (WDAY) Exhibits Mixed Performance in Stock Market: Analysis and Factors to Consider on February 13, 2024

On February 13, 2024, Workday Inc. (WDAY) exhibited a mixed performance in the stock market. The stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating positive price momentum. However, the price of WDAY shares experienced a slight decrease of $0.93 since the market last closed, representing a 0.31% drop. This decline suggests that investors may have taken some profits or that there was selling pressure in the market. The stock opened at $290.40, which was $8.69 lower than its previous close. This indicates a significant gap down in the stock’s price at the opening bell. Such a gap down opening could be attributed to various factors, such as negative news, market sentiment, or profit-taking by investors. Despite the initial drop in price, it is important to note that WDAY was still trading near the top of its 52-week range. This suggests that the stock has been performing relatively well and has gained positive momentum over the past year. Investors should consider these factors when analyzing WDAY’s performance on February 13, 2024. While the stock experienced a slight decrease in price and a gap down opening, it is still trading near its 52-week high and above its 200-day simple moving average, indicating overall positive momentum in the stock.

Workday Inc. (WDAY) Stock Shows Positive Performance with Improved Total Revenue and Net Income

On February 13, 2024, Workday Inc. (WDAY) stock exhibited positive performance, with both total revenue and net income showing improvement compared to the previous year and quarter. According to data sourced from CNN Money, Workday’s total revenue for the past year stood at $6.20 billion, representing a significant increase of 20.42% compared to the previous year. The company’s total revenue for the third quarter was $1.85 billion, reflecting a more modest but still impressive increase of 4.55% since the previous quarter. In terms of net income, Workday experienced a significant improvement since the previous quarter. The company reported a net income of -$366.75 million for the past year, indicating a decrease of 1348.59% compared to the previous year. However, in the third quarter, Workday’s net income rebounded, reaching $113.71 million, representing an impressive increase of 44.56% since the previous quarter. Despite the improvement in net income, it is worth noting that Workday still reported negative earnings per share (EPS). The EPS for the past year was -$1.44, indicating a decrease of 1344.98% compared to the previous year. However, in the third quarter, the EPS showed a positive trend, reaching $0.43, representing an increase of 43.5% since the previous quarter. Overall, Workday’s stock performances on February 13, 2024, were positive, with both total revenue and net income showing improvement compared to the previous year and quarter.

Tags: WDAY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

The Remarkable Influence of Compounded Returns A Case Study of TakeTwo Interactive

Analyst Ratings and Price Target Adjustments for Blueprint Medicines

Healthcare-sector

Delta Apparel Resumes Stock Repurchase Program to Boost Market Position and Show Confidence in Future Prospects

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com